Literature DB >> 12366672

A case of metastatic malignant hemangiopericytoma of the ovary: recurrence after a period of 17 years from intracranial tumor.

M Begum1, H Katabuchi, H Tashiro, Y Suenaga, H Okamura.   

Abstract

Hemangiopericytoma is an uncommon vascular tumor. Primary or metastatic hemangiopericytoma of the ovary is extremely rare. A 48-year-old Japanese woman had a tumor in the neck. Simultaneously, a solid ovarian tumor was detected. She had received treatment for intracranial hemangiopericytoma 17 years previously. For the ovarian tumor, she underwent a total abdominal hysterectomy and bilateral salpingo-oophorectomy. The left ovarian tumor weighed 1510 g and its cut surface was solid without areas of hemorrhage or necrosis. It was microscopically composed of tightly packed tumor cells outside of many vascular vessels. One or two mitotic figures were counted per 10 high power fields. Immunohistochemically, vimentin was expressed but factor-VIII-related antigen, CD 31, and CD 34 were not expressed in the tumor cells. Electron microscopy showed that the tumor cells were grown outside of the endothelium-lined vascular spaces. A discontinuous external basal lamina was also observed. We present a case of metastatic malignant hemangiopericytoma of the ovary from a primary intracranial hemangiopericytoma with a long interval of 17 years.

Entities:  

Mesh:

Year:  2002        PMID: 12366672     DOI: 10.1046/j.1525-1438.2002.t01-1-01148.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  2 in total

1.  Metastatic liver cancer: a rare case.

Authors:  Bong-Wan Kim; Hee-Jung Wang; In-Ho Jeong; Sang-Ick Ahn; Myoung-Wook Kim
Journal:  World J Gastroenterol       Date:  2005-07-21       Impact factor: 5.742

2.  Surveillance for metastatic hemangiopericytoma-solitary fibrous tumors-systematic literature review on incidence, predictors and diagnosis of extra-cranial disease.

Authors:  Tarini Ratneswaren; Florence Rosie Avila Hogg; Mathew Joseph Gallagher; Keyoumars Ashkan
Journal:  J Neurooncol       Date:  2018-03-17       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.